The expression of EMCN (also called endomucin), which is expressed in endothelial cells, was downregulated and associated with better overall survival in VHL-mutant ccRCC patients (Wang et al., 2022). This evidence concerns the gene EMCN and nonpapillary renal cell carcinoma.